文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

通过重复 NIHSS 测量评估的神经功能轨迹与缺血性卒中后长期心血管事件、复发性卒中及死亡率之间的关系。

The relationship between neurological function trajectory, assessed by repeated NIHSS measurement, and long-term cardiovascular events, recurrent stroke, and mortality after ischemic stroke.

机构信息

Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou, China.

Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou, China.

出版信息

Int J Stroke. 2023 Oct;18(8):1005-1014. doi: 10.1177/17474930231180446. Epub 2023 Jun 7.


DOI:10.1177/17474930231180446
PMID:37226318
Abstract

BACKGROUND: Clinically significant changes in neurological deficits frequently occur after stroke onset, reflecting further neurological injury or neurological improvement. However, the National Institutes of Health Stroke Scale (NIHSS) score is only evaluated once in most studies, usually at stroke onset. Utilizing repeated measures of NIHSS scores to identify different trajectories of neurological function may be more informative and provide more useful predictive information. We determined the association of neurological function trajectories with long-term clinical outcomes after ischemic stroke. METHODS: A total of 4025 participants with ischemic stroke from the China Antihypertensive Trial in Acute Ischemic Stroke were included. Patients were recruited from 26 hospitals across China between August 2009 and May 2013. A group-based trajectory model was used to identify distinct neurological function trajectories, as measured by NIHSS at admission, 14 days or hospital discharge, and 3 months. Study outcomes were cardiovascular events, recurrent stroke, and all-cause mortality during 3-24 months after ischemic stroke onset. Cox proportional hazards models were used to examine the associations of neurological function trajectories with outcomes. RESULTS: We identified three distinct subgroups of NIHSS trajectories: persistent severe (persistent high NIHSS scores during the 3-month follow-up), moderate (NIHSS scores started at around 5 and gradually reduced), and mild (NIHSS scores always below 2). The three trajectory groups had different clinical profiles and different risk of stroke outcomes at 24-month follow-up. Compared to the mild trajectory group, patients in the persistent severe trajectory group had a higher risk of cardiovascular events (multivariable-adjusted hazard ratios (95% confidence intervals) = 1.77 (1.10-2.86)), recurrent stroke (1.82 (1.10-3.00)), and all-cause mortality (5.64 (3.37-9.43)). Those with moderate trajectory had an intermediate risk: 1.45 (1.03-2.04) for cardiovascular events and 1.52 (1.06-2.19) for recurrent stroke. CONCLUSION: Longitudinal neurological function trajectories derived from repeated NIHSS measurements during the first 3 months after stroke provide additional predictive information and are associated with long-term clinical outcomes. The trajectories characterized by persistent severe and moderate neurological impairment were associated with increased risk of subsequent cardiovascular events.

摘要

背景:在脑卒中后,神经功能缺损常出现临床意义上的变化,这反映了进一步的神经损伤或神经改善。然而,在大多数研究中,美国国立卫生研究院卒中量表(NIHSS)评分通常仅在卒中发病时评估一次。利用 NIHSS 评分的重复测量来识别神经功能的不同轨迹可能更具信息量,并提供更有用的预测信息。我们确定了神经功能轨迹与缺血性卒中后长期临床结局的关系。

方法:共有 4025 例来自中国急性缺血性脑卒中降压试验的缺血性卒中患者被纳入研究。这些患者于 2009 年 8 月至 2013 年 5 月间从中国 26 家医院招募。采用基于群组的轨迹模型来识别不同的神经功能轨迹,这些轨迹通过 NIHSS 在入院时、14 天或出院时和 3 个月时进行测量。研究结局是卒中发病后 3-24 个月的心血管事件、复发性卒中及全因死亡率。采用 Cox 比例风险模型来检验神经功能轨迹与结局的关系。

结果:我们确定了 NIHSS 轨迹的三个不同亚组:持续性严重(3 个月随访期间 NIHSS 评分持续升高)、中度(NIHSS 评分在 5 左右开始,逐渐降低)和轻度(NIHSS 评分始终低于 2)。这三个轨迹组具有不同的临床特征和 24 个月随访时的卒中结局风险。与轻度轨迹组相比,持续性严重轨迹组患者发生心血管事件的风险更高(多变量校正的风险比(95%置信区间)= 1.77(1.10-2.86))、复发性卒中(1.82(1.10-3.00))和全因死亡率(5.64(3.37-9.43))。中度轨迹组患者的风险处于中间水平:心血管事件 1.45(1.03-2.04),复发性卒中 1.52(1.06-2.19)。

结论:卒中发病后 3 个月内通过重复 NIHSS 测量得出的纵向神经功能轨迹提供了额外的预测信息,并与长期临床结局相关。以持续性严重和中度神经功能障碍为特征的轨迹与随后发生心血管事件的风险增加相关。

相似文献

[1]
The relationship between neurological function trajectory, assessed by repeated NIHSS measurement, and long-term cardiovascular events, recurrent stroke, and mortality after ischemic stroke.

Int J Stroke. 2023-10

[2]
One-Year Disability Trajectories and Long-Term Cardiovascular Events, Recurrent Stroke, and Mortality After Ischemic Stroke.

J Am Heart Assoc. 2024-2-6

[3]
Early Trajectory of Stroke Severity Predicts Long-Term Functional Outcomes in Ischemic Stroke Subjects: Results From the ESCAPE Trial (Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion With Emphasis on Minimizing CT to Recanalization Times).

Stroke. 2017-1

[4]
Systolic Blood Pressure Trajectories in the Acute Phase and Clinical Outcomes in 2-Year Follow-up Among Patients With Ischemic Stroke.

Am J Hypertens. 2019-2-12

[5]
Clinical Characteristics and In-Hospital Outcomes of Varying Definitions of Minor Stroke: From a Large-Scale Nation-Wide Longitudinal Registry.

Stroke. 2021-4

[6]
National Institutes of Health stroke scale score at admission can predict functional outcomes in patients with ischemic stroke undergoing carotid endarterectomy.

J Vasc Surg. 2022-5

[7]
Prognostic significance of plasma SDF-1 in acute ischemic stroke patients with diabetes mellitus: the CATIS trial.

Cardiovasc Diabetol. 2023-10-10

[8]
Trajectories of stroke severity and functional outcomes after endovascular treatment in ischemic stroke: A post hoc analysis of a randomized controlled trial.

Clin Neurol Neurosurg. 2024-4

[9]
Prognosis of Neurological Improvement in Inpatient Acute Ischemic Stroke Survivors: A Propensity Score Matching Analysis.

J Stroke Cerebrovasc Dis. 2021-1

[10]
Hypercoagulation on Thromboelastography Predicts Early Neurological Deterioration in Patients with Acute Ischemic Stroke.

Cerebrovasc Dis. 2018

引用本文的文献

[1]
Association of alkaline-phosphatase/albumin ratio with all-cause mortality in critically ill patients with ischemic stroke: a retrospective study.

Front Neurol. 2025-4-30

[2]
Late neurological improvement during hospitalization is a predicative factor for acute ischemic stroke.

Eur J Med Res. 2025-4-24

[3]
Outcomes, neurological function, and inflammation indices following minimally invasive hematoma removal in hypertensive cerebral hemorrhage patients.

Am J Transl Res. 2025-2-25

[4]
Argatroban plus alteplase in posterior versus anterior circulation stroke.

Ann Clin Transl Neurol. 2025-2

[5]
Enhancing Understanding of Acute Ischemic Stroke Research in the Elderly: A Discussion on the Importance of Inflammatory Markers [Letter].

Clin Interv Aging. 2024-11-11

[6]
Isoliquiritigenin alleviates cerebral ischemia-reperfusion injury by reducing oxidative stress and ameliorating mitochondrial dysfunction via activating the Nrf2 pathway.

Redox Biol. 2024-11

[7]
The Role of Platelet Distribution Width in the Association Between Blood Glucose and Neurological Impairment Severity in Acute Ischemic Stroke: A Moderated Mediation Model.

J Inflamm Res. 2024-9-4

[8]
Short-Term and Long-Term Risk of Recurrent Vascular Event by Cause After Ischemic Stroke in Young Adults.

JAMA Netw Open. 2024-2-5

[9]
One-Year Disability Trajectories and Long-Term Cardiovascular Events, Recurrent Stroke, and Mortality After Ischemic Stroke.

J Am Heart Assoc. 2024-2-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索